Chair of Pharmaceutical Radiochemistry, Technical University Munich
Hans-Jürgen studied Chemistry at the University of Cologne (Diploma 1992 in Radiochemistry) and joined the Nuclear Research Center Juelich GER for his Doctoral Thesis (1996, Ph.D. in Radiopharmaceutical Chem.). Thereafter he became Scientific Assistant (1996-97) and Research associate (1998-2003) at the Department of Nucl.Med., Technical University Munich (TUM). In 2003 he received several Offers (Associate and Full Professorships) by US and German Universities and became Professor (C3) of Radiopharmaceutical Chemistry (2004-2010, TUM, Faculty of Medicine, Dept. of Nucl.Med., with coappointment at the Faculty of Chemistry). Since 2010 he is Full Professor (W3) for Pharmaceutical Radiochemistry at the TUM, 1st full appointment at the Faculty of Chemistry, 2nd full appointment at the Faculty of Medicine. Hans-Jürgen founded SCINTOMICS GmbH in 2006 and was CEO until 2015. His research focusses on the development of molecular probes for the non-invasive imaging of diseases, new strategies for production of radiopharmaceuticals, radionuclide therapy, tissue selective targeting of imaging probes and therapeutic compounds, transfer of genomic and proteomic information into new imaging methods.
>390 Publications, h-factor: 64 (03.2018)